Baidu
map

刚刚,中科院预警期刊名单发布

2021-12-31 中科院文献情报中心分区表、MDPI,学之策 中科院文献情报中心分区表、MDPI,学之策

中科院文献情报中心分区表首次发布消息

2020年12月4日,中科院文献情报中心分区表首次发布消息,称将推出《国际期刊预警名单》,具体名单将采用定性与定量相结合的方法确定。

“定性”应该是基于专家评价和口碑之类来定,具有较大的不确定性。而“定量”则明确指出根据期刊载文量、作者国际化程度、拒稿率、论文处理费、期刊超越指数、自引率和撤稿信息综合评判。

去年12月31日,发布了首次预警名单。

今天,期刊分区表团队结合专家咨询结果和计量指标表现,发布了2021年度《国际期刊预警名单(试行) 》。期刊预警不是论文评价,更不是否定预警期刊发表的每项成果。预警期刊旨在提醒科研人员审慎选择成果发表平台、提示出版机构强化期刊质量管理

下面的名单都会集成到MedSci 的期刊查询中,敬请查询:最新SCI期刊智能查询及投稿系统(2020-2021年)

2021年度《国际期刊预警名单(试行)》

刚刚,中科院预警期刊名单发布

 

下面是2020年的目录,大家可以对照一下。

刚刚,中科院预警期刊名单发布

 

今年的预警名单中很多MDPI的期刊被移除了。去年分区表发布之后,MDPI出版社也进行了回应。

2020年12月31日,中国科学院文献情报中心期刊分区表团队发布《国际期刊预警名单(试行)》,MDPI出版社众多期刊上榜,MDPI随后在其公众号“MDPI开放数字出版”发表了如下声明

2020年12月31日,中国科学院文献情报中心期刊分区表团队发布《国际期刊预警名单(试行)》(以下简称《预警名单》),通过综合评判期刊载文量、作者国际化程度、拒稿率、论文处理费 (APC)、期刊超越指数、自引率、撤稿信息等因素,标识了一些可能具备潜在风险特征的学术期刊,包含有部分MDPI的期刊,但并没有明确指出这些期刊的入选原因和每个入选指标的合理阈值。我们针对此情况向中科院文献情报中心分区表负责人咨询了具体筛选标准,并进行了积极的面对面沟通。

中科院文献情报中心分区表负责人表示,《预警名单》并非否定预警期刊上发表的成果,而是旨在提醒出版机构强化期刊管理,激励期刊不断提升其质量及影响力。自创立以来,MDPI始终坚持开放科学的初心,旨在通过提供高效、专业、优质的学术出版服务,建立更具协作性、包容性和透明性的科研平台。MDPI期刊一直采用高标准的同行评议流程,所有投稿都必须经过外部专家严格的质量评估。据MDPI于2020年发起的《中国学者研究成果发表需求》报告显示,中国学者对MDPI出版服务的满意度为85%,净推荐值为97%。得益于各领域学者的信任和支持,MDPI期刊投稿量和发表量也在不断攀升。由于期刊逐年增量,其影响力数值 (单篇论文和相同领域内其他期刊论文相比的影响力) 也受到了不同程度的影响,进而导致期刊超越指数产生波动。如表一所示大部分MDPI预警期刊的JCR影响因子都在逐年攀升,这也说明期刊的总体质量是在不断提升的。据2020年期刊全年发文数据显示,在MDPI期刊发文量排名前五的国家主要为中国 (17.73%)、美国 (13.85%)、意大利 (10.25%)、西班牙 (8.48%) 和韩国 (7.53%),期刊整体拒稿率为53.87%,撤稿率为0.02%。据2020年6月科睿唯安发布的《期刊引证报告》,MDPI有18本期刊收获第一个影响因子,72%的MDPI期刊影响因子有所提高。此外,2020年全年MDPI共计新增10本SCIE收录期刊,SCIE收录的期刊数量达到80本。

刚刚,中科院预警期刊名单发布

表一 MDPI部分期刊近五年影响因子 (IF) 变化

中科院文献情报中心分区表负责人强调,《预警期刊》的正式名单以及更新频率目前尚未确定,会对试行版名单上的期刊进行持续监测。MDPI会根据沟通结果,进一步精益求精,优化期刊各方面参数,并持续和分区表保持沟通早日把期刊从预警名单上撤下来。

公平、诚信是科研群体和学术出版商共同呼吁的科学精神,MDPI会一如既往地秉承科学精神,进一步加强期刊内部管理,自觉担任起学术质量守门人的责任,与全球科研界同行携手维护科研领域的基本秩序,共同营造科研群体的社会公信力和学术权威,创造更加公平、活跃、开放的科研氛围。

MDPI中国区市场部

 

今年10月,MDPI再度发表声明

刚刚,中科院预警期刊名单发布

 

不过,目前已有多所国内高校似乎正式建立了各自的期刊预警名单。不同高校的期刊预警名单命名方式各不相同,包括《期刊黑名单》、《“重点监控期刊”目录》等。

版权声明:本文内容转自中科院文献情报中心分区表、MDPI,学之策等,转载只为了学术交流,版权归原作者所有,如涉及侵权问题,请联系我们,我们将及时修改或删除。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1862701, encodeId=44601862e015b, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Aug 06 02:48:29 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216571, encodeId=877b12165e1c2, content=现在frontiers in medicine能投吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae45401046, createdName=ms5000000137492518, createdTime=Tue May 03 15:29:41 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182202, encodeId=9c8a1182202a2, content=太瞎了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb635501875, createdName=ms7000000508416078, createdTime=Sat Jan 08 14:15:43 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179296, encodeId=8a8611e9296e6, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:45:07 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179293, encodeId=5dbe11e929390, content=没有plos one和medicine?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa105553537, createdName=奥曲肽, createdTime=Fri Dec 31 14:42:00 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-08-06 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=1862701, encodeId=44601862e015b, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Aug 06 02:48:29 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216571, encodeId=877b12165e1c2, content=现在frontiers in medicine能投吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae45401046, createdName=ms5000000137492518, createdTime=Tue May 03 15:29:41 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182202, encodeId=9c8a1182202a2, content=太瞎了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb635501875, createdName=ms7000000508416078, createdTime=Sat Jan 08 14:15:43 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179296, encodeId=8a8611e9296e6, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:45:07 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179293, encodeId=5dbe11e929390, content=没有plos one和medicine?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa105553537, createdName=奥曲肽, createdTime=Fri Dec 31 14:42:00 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-05-03 ms5000000137492518

    现在frontiers in medicine能投吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1862701, encodeId=44601862e015b, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Aug 06 02:48:29 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216571, encodeId=877b12165e1c2, content=现在frontiers in medicine能投吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae45401046, createdName=ms5000000137492518, createdTime=Tue May 03 15:29:41 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182202, encodeId=9c8a1182202a2, content=太瞎了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb635501875, createdName=ms7000000508416078, createdTime=Sat Jan 08 14:15:43 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179296, encodeId=8a8611e9296e6, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:45:07 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179293, encodeId=5dbe11e929390, content=没有plos one和medicine?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa105553537, createdName=奥曲肽, createdTime=Fri Dec 31 14:42:00 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2022-01-08 ms7000000508416078

    太瞎了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1862701, encodeId=44601862e015b, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Aug 06 02:48:29 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216571, encodeId=877b12165e1c2, content=现在frontiers in medicine能投吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae45401046, createdName=ms5000000137492518, createdTime=Tue May 03 15:29:41 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182202, encodeId=9c8a1182202a2, content=太瞎了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb635501875, createdName=ms7000000508416078, createdTime=Sat Jan 08 14:15:43 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179296, encodeId=8a8611e9296e6, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:45:07 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179293, encodeId=5dbe11e929390, content=没有plos one和medicine?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa105553537, createdName=奥曲肽, createdTime=Fri Dec 31 14:42:00 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-12-31 仁术2021

    不错学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1862701, encodeId=44601862e015b, content=<a href='/topic/show?id=a121223385b' target=_blank style='color:#2F92EE;'>#中科院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22338, encryptionId=a121223385b, topicName=中科院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Aug 06 02:48:29 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216571, encodeId=877b12165e1c2, content=现在frontiers in medicine能投吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae45401046, createdName=ms5000000137492518, createdTime=Tue May 03 15:29:41 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182202, encodeId=9c8a1182202a2, content=太瞎了, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb635501875, createdName=ms7000000508416078, createdTime=Sat Jan 08 14:15:43 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179296, encodeId=8a8611e9296e6, content=不错学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210606/e8b96fdba070433da10cd357c0646807/28bf16f46e314caaad8396c0c7df7a04.jpg, createdBy=adb15496357, createdName=仁术2021, createdTime=Fri Dec 31 14:45:07 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179293, encodeId=5dbe11e929390, content=没有plos one和medicine?, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa105553537, createdName=奥曲肽, createdTime=Fri Dec 31 14:42:00 CST 2021, time=2021-12-31, status=1, ipAttribution=)]
    2021-12-31 奥曲肽

    没有plos one和medicine?

    0

Baidu
map
Baidu
map
Baidu
map